Efficacy observation of the combination of Weimaining capsule and XELOX regimen in the treatment of advanced gastric cancer patients
10.3760/cma.j.issn.1006-9801.2014.05.013
- VernacularTitle:威麦宁胶囊联合XELOX方案治疗晚期胃癌的效果观察
- Author:
Lingmin HAN
;
Lin YANG
;
Pingping WANG
- Publication Type:Journal Article
- Keywords:
Advanced gastric cancer;
Weimaining capsule;
Oxaliplatin;
Capecitabine
- From:
Cancer Research and Clinic
2014;26(5):336-338,341
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of the combination of Weimaining capsule and XELOX regimen (oxaliplatin plus capecitabine) in the treatment of advanced gastric cancer patients.Methods A total of 62 patients with advanced gastric cancer who fulfilled all predetermined criteria were randomly divided into observation group and control group.The 31 patients in observation group received a combination of Weimaining capsule and XELOX regimen,the 31 patients in control group received only XELOX regimen at the same dose intensity.Each patient received at least two cycles (1 cycle =21 days) of treatment,the efficacy was assessed after two cycles.Results The median time-to-progression (TTP) of observation and control groups were 5.5 and 4.8 months,respectively.The difference had no statistical significance (P =0.238).The disease control rates (DCR) of observation group was significantly improved compared with control group [67.7 % (21/31) vs 41.9 % (13/21),P < 0.05],the difference was statistically significant,while the objective response rate (ORR) of the 2 groups had no statistical difference [(32.3 % (10/31) vs 25.8 % (8/31),P > 0.05].In drug safety aspects,there was no Ⅴ grade adverse reactions (deaths caused by drug) among all the patients.Rates of grades Ⅱ-Ⅳ neutrocytopenia and nausea,vomiting in observation group were obviously lower than control group [16.13 % (5/31) vs 38.71% (12/31),P < 0.05;12.90 % (4/31) vs 35.48 % (11/31),P < 0.05],other adverse reactions between the 2 groups had no statistical difference.Conclusions A combination of Weimaining capsule and XELOX regimen in the treatment of advanced gastric cancer patients can improve DCR significantly and reduce part of adverse reaction induced by chemotherapy with satisfactory safety.This method is worthy of application widely.